The patient voice: Moving to Amgevita

Contributor
He Ako Hiringa
14 April 2022

This short video explores what patients think about the move to Amgevita. We spoke to a group of seven New Zealanders living with arthritis to find out how they feel about changing from the biological reference medicine, Humira, to the new biosimilar medicine, Amgevita.